HER2 Negative Breast Carcinoma Expressing CEA
1 clinical trials · Condition
◉ Watch HER2 Negative Breast Carcinoma Expressing CEA
| Record | Firm | Date |
|---|---|---|
| ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA (NCT01730612) | Nantes University Hospital | 2012-12-01 |
Track HER2 Negative Breast Carcinoma Expressing CEA automatically
Every clearance here is in the API, with alerts when new ones post.